Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Earnings
Vaccinex's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Vaccinex's earnings releases, newest first
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Vaccinex has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Vaccinex puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Vaccinex filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- News
- Update
- News
- Update
- News
- News
- Update
- Update
- News
- Update
- Update
- Update
- News
- Update
See a number that looks wrong?